Harmless Rocaglamide makes Apoptosis Inducing Drugs more Effective
Rocaglamide makes tumour cells more susceptible to anti-proliferative agents while leaving normal cells unaffected. This allows dose reduction of apoptosis inducers and in parallel improves dramatically the patient’s condition during cancer treatment.
Further information: PDF
DKFZ (German Cancer Research Center, Deutsches Krebsforschungszentrum)
Phone: +49-6221-42 2955
Contact
Dr. Ruth Herzog
As Germany's association of technology- and patenttransfer agencies TechnologieAllianz e.V. is offering businesses access to the entire range of innovative research results of almost all German universities and numerous non-university research institutions. More than 2000 technology offers of 14 branches are beeing made accessable to businesses in order to assure your advance on the market. At www.technologieallianz.de a free, fast and non-bureaucratic access to all further offers of the German research landscape is offered to our members aiming to sucessfully transfer technologies.
Media Contact
All latest news from the category: Technology Offerings
Newest articles
Tailored Fitness Programs Linked to Increased Life Expectancy in Cancer Patients
Tailored exercise may prolong life in these patients, suggest researchers Muscular strength and good physical fitness are linked to a significantly lower risk of death from any cause in people…
Going Green: Fighting Freshwater Salt Pollution with Phytoremediation
Salt pollution in freshwater is a growing global concern. Excessive salt harms plants, degrades soil, and compromises water quality. In urban areas, road salts used for de-icing during winter often…
Psoriasis Patients at Increased Risk for Crohn’s Due to Gut Inflammation
People with the skin condition psoriasis often have invisible inflammation in the small intestine with an increased propensity for ‘leaky gut’, according to new research at Uppsala University. These changes…